Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if LGVN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
7 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 2
39 filers reported a long position in LGVN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | $951.8K | 1.4M | +203.1% |
| Logos Global Management LP | $904.8K | 1.3M | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $408.7K | 581.3K | +7.2% |
| BlackRock, Inc. | $157.6K | 224.2K | 0% |
| GEODE CAPITAL MANAGEMENT, LLC | $143.2K | 203.8K | +0.1% |
| JANE STREET GROUP, LLC | $133.8K | 190.4K | +2.5% |
| VANGUARD FIDUCIARY TRUST CO | $98.5K | 140.1K | +261.9% |
| Mariner, LLC | $88.6K | 126K | New |
| ADAR1 Capital Management, LLC | $76.2K | 108.4K | -45.8% |
| Beacon Pointe Advisors, LLC | $70.3K | 100K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.